Basilea Pharmaceutica Ag Stock Price on September 23, 2024
| BPMUF Stock | USD 52.83 0.00 0.00% |
If you're considering investing in Basilea Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Basilea Pharmaceutica stands at 52.83, as last reported on the 4th of December, with the highest price reaching 52.83 and the lowest price hitting 52.83 during the day. At this point, Basilea Pharmaceutica is very steady. Basilea Pharmaceutica secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We have found seventeen technical indicators for Basilea Pharmaceutica AG, which you can use to evaluate the volatility of the firm. Please confirm Basilea Pharmaceutica's Risk Adjusted Performance of 0.0837, mean deviation of 0.0914, and Standard Deviation of 0.377 to double-check if the risk estimate we provide is consistent with the expected return of 0.0479%.
Basilea Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Basilea |
Sharpe Ratio = 0.125
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BPMUF |
Estimated Market Risk
| 0.38 actual daily | 3 97% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Basilea Pharmaceutica is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Basilea Pharmaceutica by adding it to a well-diversified portfolio.
Related Headline
Protalix Biotherapeutics Headline on 23rd of September 2024
Acquisition by Yaron Naos of 100000 shares of Protalix Bioth... by MacroaxisInsider
Filed transaction by Protalix Biotherapeutics Officer: Sr. Vp, Operations. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Basilea Pharmaceutica Valuation on September 23, 2024
It is possible to determine the worth of Basilea Pharmaceutica on a given historical date. On September 23, 2024 Basilea was worth 51.26 at the beginning of the trading date compared to the closed value of 51.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Basilea Pharmaceutica pink sheet. Still, in general, we apply an absolute valuation method to find Basilea Pharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Basilea Pharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Basilea Pharmaceutica's related companies.
| Open | High | Low | Close | Volume | |
| 44.45 | 51.26 | 44.45 | 51.26 | 100.00 | |
09/23/2024 | 51.26 | 51.26 | 51.26 | 51.26 | 1.00 |
| 51.26 | 51.26 | 51.26 | 51.26 | 1.00 |
| Backtest Basilea Pharmaceutica | | | Basilea Pharmaceutica History | | | Basilea Pharmaceutica Valuation | Previous | Next |
Basilea Pharmaceutica Trading Date Momentum on September 23, 2024
| On September 24 2024 Basilea Pharmaceutica AG was traded for 51.26 at the closing time. The highest daily price throughout the period was 51.26 and the lowest price was 51.26 . There was no trading activity during the period 1.0. Lack of trading volume on 09/24/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Basilea Pharmaceutica Fundamentals Correlations and Trends
By evaluating Basilea Pharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Basilea Pharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Basilea financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Basilea Pharmaceutica Pink Sheet history
Basilea Pharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Basilea is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Basilea Pharmaceutica will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Basilea Pharmaceutica stock prices may prove useful in developing a viable investing in Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Basel, Switzerland. BASILEA PHARMACEUTICA is traded on OTC Exchange in the United States.
Basilea Pharmaceutica Pink Sheet Technical Analysis
Basilea Pharmaceutica technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Basilea Pharmaceutica Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Basilea Pharmaceutica AG cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Basilea Pharmaceutica December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Basilea Pharmaceutica pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Basilea Pharmaceutica shares will generate the highest return on investment. By undertsting and applying Basilea Pharmaceutica pink sheet market strength indicators, traders can identify Basilea Pharmaceutica AG entry and exit signals to maximize returns
Basilea Pharmaceutica Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Basilea Pharmaceutica's price direction in advance. Along with the technical and fundamental analysis of Basilea Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Basilea to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0837 | |||
| Jensen Alpha | 0.0334 | |||
| Total Risk Alpha | (0.01) | |||
| Treynor Ratio | 1.26 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Basilea Pink Sheet analysis
When running Basilea Pharmaceutica's price analysis, check to measure Basilea Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Basilea Pharmaceutica is operating at the current time. Most of Basilea Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Basilea Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Basilea Pharmaceutica's price. Additionally, you may evaluate how the addition of Basilea Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |